Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-13 1:14 pm Sale |
2024-09-30 | 13G | G1 Therapeutics, Inc. GTHX |
Beryl Capital Management LLC | 0 0.000% |
-5,179,529 (Position Closed) |
Filing History |
| 2024-08-19 7:02 pm Purchase |
2024-08-07 | 13G | G1 Therapeutics, Inc. GTHX |
Beryl Capital Management LLC | 5,179,529 9.800% |
5,179,529 (New Position) |
Filing History |
| 2024-02-21 4:30 pm Purchase |
2022-11-18 | 13D | G1 Therapeutics, Inc. GTHX |
ESHELMAN FREDRIC N | 4,766,074 9.260% |
1,072,479 (+29.04%) |
Filing History |
| 2024-02-05 3:37 pm Purchase |
2023-05-08 | 13G | G1 Therapeutics, Inc. GTHX |
FISHER INVESTMENTS INC | 1,000 0.000% |
1,000 (New Position) |
Filing History |
| 2023-02-09 11:19 am Sale |
2022-12-30 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 1,925,845 3.810% |
-618,520 (-24.31%) |
Filing History |
| 2023-02-03 11:47 am Purchase |
2022-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
179,736 0.360% |
37,530 (+26.39%) |
Filing History |
| 2022-12-06 10:35 am Sale |
2022-11-30 | 13G | G1 Therapeutics, Inc. GTHX |
J P MORGAN CHASE & CO JPM |
2,045,814 4.000% |
-94,034 (-4.39%) |
Filing History |
| 2022-07-11 1:20 pm Sale |
2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
142,206 0.330% |
-4,159,407 (-96.69%) |
Filing History |
| 2022-07-08 4:56 pm Sale |
2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX |
BLACKROCK INC BLK |
1,369,281 3.200% |
-1,940,931 (-58.63%) |
Filing History |
| 2022-02-11 08:12 am Sale |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
4,301,613 10.120% |
-81,999 (-1.87%) |
Filing History |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 2,544,365 5.980% |
448,638 (+21.41%) |
Filing History |
| 2022-02-03 4:41 pm Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
BLACKROCK INC BLK |
3,310,212 7.800% |
416,619 (+14.40%) |
Filing History |
| 2022-01-21 11:43 am Purchase |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
J P MORGAN CHASE & CO JPM |
2,139,848 5.000% |
2,139,848 (New Position) |
Filing History |
| 2021-10-12 12:30 pm Purchase |
2021-09-30 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
4,383,612 10.350% |
1,803,793 (+69.92%) |
Filing History |
| 2021-02-12 4:16 pm Sale |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
Hatteras Venture Partners IV SBIC LP | 1,756,462 4.600% |
-259,926 (-12.89%) |
Filing History |
| 2021-02-11 1:07 pm Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
2,579,819 6.780% |
2,579,819 (New Position) |
Filing History |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
The Vanguard Group | 2,095,727 5.510% |
82,162 (+4.08%) |
Filing History |
| 2021-02-08 10:23 am Sale |
2021-02-05 | 13G | G1 Therapeutics, Inc. GTHX |
FMR CORP | 923,939 2.428% |
-1,620,598 (-63.69%) |
Filing History |
| 2021-02-03 1:33 pm Sale |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
WELLINGTON MANAGEMENT CO LLP | 1,237,342 3.250% |
-1,719,213 (-58.15%) |
Filing History |
| 2021-01-29 09:57 am Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
BLACKROCK INC BLK |
2,893,593 7.600% |
313,234 (+12.14%) |
Filing History |